Cargando…
Genetic modulation of oxytocin sensitivity: a pharmacogenetic approach
Intranasal administration of the neuropeptide oxytocin has been shown to influence a range of complex social cognitions and social behaviors, and it holds therapeutic potential for the treatment of mental disorders characterized by social functioning deficits such as autism, social phobia and border...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930136/ https://www.ncbi.nlm.nih.gov/pubmed/26506050 http://dx.doi.org/10.1038/tp.2015.163 |
_version_ | 1782440702012030976 |
---|---|
author | Chen, F S Kumsta, R Dvorak, F Domes, G Yim, O S Ebstein, R P Heinrichs, M |
author_facet | Chen, F S Kumsta, R Dvorak, F Domes, G Yim, O S Ebstein, R P Heinrichs, M |
author_sort | Chen, F S |
collection | PubMed |
description | Intranasal administration of the neuropeptide oxytocin has been shown to influence a range of complex social cognitions and social behaviors, and it holds therapeutic potential for the treatment of mental disorders characterized by social functioning deficits such as autism, social phobia and borderline personality disorder. However, considerable variability exists in individual responses to oxytocin administration. Here, we undertook a study to investigate the role of genetic variation in sensitivity to exogenous oxytocin using a socioemotional task. In a randomized, double-blind, placebo-controlled experiment with a repeated-measures (crossover) design, we assessed the performance of 203 men on an emotion recognition task under oxytocin and placebo. We took a haplotype-based approach to investigate the association between oxytocin receptor gene variation and oxytocin sensitivity. We identified a six-marker haplotype block spanning the promoter region and intron 3 that was significantly associated with our measure of oxytocin sensitivity. Specifically, the TTCGGG haplotype comprising single-nucleotide polymorphisms rs237917–rs2268498–rs4564970–rs237897–rs2268495–rs53576 is associated with increased emotion recognition performance under oxytocin versus placebo, and the CCGAGA haplotype with the opposite pattern. These results on the genetic modulation of sensitivity to oxytocin document a significant source of individual differences with implications for personalized treatment approaches using oxytocin administration. |
format | Online Article Text |
id | pubmed-4930136 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-49301362016-07-14 Genetic modulation of oxytocin sensitivity: a pharmacogenetic approach Chen, F S Kumsta, R Dvorak, F Domes, G Yim, O S Ebstein, R P Heinrichs, M Transl Psychiatry Original Article Intranasal administration of the neuropeptide oxytocin has been shown to influence a range of complex social cognitions and social behaviors, and it holds therapeutic potential for the treatment of mental disorders characterized by social functioning deficits such as autism, social phobia and borderline personality disorder. However, considerable variability exists in individual responses to oxytocin administration. Here, we undertook a study to investigate the role of genetic variation in sensitivity to exogenous oxytocin using a socioemotional task. In a randomized, double-blind, placebo-controlled experiment with a repeated-measures (crossover) design, we assessed the performance of 203 men on an emotion recognition task under oxytocin and placebo. We took a haplotype-based approach to investigate the association between oxytocin receptor gene variation and oxytocin sensitivity. We identified a six-marker haplotype block spanning the promoter region and intron 3 that was significantly associated with our measure of oxytocin sensitivity. Specifically, the TTCGGG haplotype comprising single-nucleotide polymorphisms rs237917–rs2268498–rs4564970–rs237897–rs2268495–rs53576 is associated with increased emotion recognition performance under oxytocin versus placebo, and the CCGAGA haplotype with the opposite pattern. These results on the genetic modulation of sensitivity to oxytocin document a significant source of individual differences with implications for personalized treatment approaches using oxytocin administration. Nature Publishing Group 2015-10 2015-10-27 /pmc/articles/PMC4930136/ /pubmed/26506050 http://dx.doi.org/10.1038/tp.2015.163 Text en Copyright © 2015 Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Original Article Chen, F S Kumsta, R Dvorak, F Domes, G Yim, O S Ebstein, R P Heinrichs, M Genetic modulation of oxytocin sensitivity: a pharmacogenetic approach |
title | Genetic modulation of oxytocin sensitivity: a pharmacogenetic approach |
title_full | Genetic modulation of oxytocin sensitivity: a pharmacogenetic approach |
title_fullStr | Genetic modulation of oxytocin sensitivity: a pharmacogenetic approach |
title_full_unstemmed | Genetic modulation of oxytocin sensitivity: a pharmacogenetic approach |
title_short | Genetic modulation of oxytocin sensitivity: a pharmacogenetic approach |
title_sort | genetic modulation of oxytocin sensitivity: a pharmacogenetic approach |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930136/ https://www.ncbi.nlm.nih.gov/pubmed/26506050 http://dx.doi.org/10.1038/tp.2015.163 |
work_keys_str_mv | AT chenfs geneticmodulationofoxytocinsensitivityapharmacogeneticapproach AT kumstar geneticmodulationofoxytocinsensitivityapharmacogeneticapproach AT dvorakf geneticmodulationofoxytocinsensitivityapharmacogeneticapproach AT domesg geneticmodulationofoxytocinsensitivityapharmacogeneticapproach AT yimos geneticmodulationofoxytocinsensitivityapharmacogeneticapproach AT ebsteinrp geneticmodulationofoxytocinsensitivityapharmacogeneticapproach AT heinrichsm geneticmodulationofoxytocinsensitivityapharmacogeneticapproach |